SP-MHCI-0366-3

Human papillomavirus type 16 Protein E6 48-57, EVYDFAFRDL

US$507.00

In stock

Description

About Human papillomavirus type 16 Protein E6 48-57, EVYDFAFRDL

The Human Papillomavirus (HPV) 16 Protein E6 Peptide (IEDB: 14909) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Protein E6 Peptide, H-EVYDFAFRDL-OH (Uniprot: P03126 aa: 48-57) from JPT is produced under strict quality control and quality management.

Human papillomavirus type 16 Protein E6 48-57, EVYDFAFRDL - Specifications

  • Peptide sequence: H-EVYDFAFRDL-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Infection
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Peptide Synthesis Services!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Human papillomavirus type 16 Protein E6 48-57, EVYDFAFRDL

References:
Read References with JPT’s Antigen Peptides
Human papillomavirus type 16 Protein E6 48-57, EVYDFAFRDL has been described in:
Immunogenicity of dendritic cell-based HPV16 E6/E7 peptide vaccines: CTL activation and protective effects., Folia Biol (Praha), 2004 (PMID: 15709713)
Tumor-associated E6 protein of human papillomavirus type 16 contains an unusual H-2Kb-restricted cytotoxic T cell epitope., J Immunol, 1995 (PMID: 7499833)
Deletion of immunoproteasome subunits imprints on the transcriptome and has a broad impact on peptides presented by major histocompatibility complex I molecules., Mol Cell Proteomics, 2010 (PMID: 20484733)

Documentation

Documentation for Human papillomavirus type 16 Protein E6 48-57, EVYDFAFRDL

Properties

Properties of Human papillomavirus type 16 Protein E6 48-57, EVYDFAFRDL

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Infection
Layout: Freeze-dried in glass vial
Organism: Human Papillomavirus (HPV)
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Human papillomavirus type 16 Protein E6 48-57, EVYDFAFRDL

Information Values
Sequence: H-EVYDFAFRDL-OH
Specifications: 10mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote